Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Innoviva
Aug 6, 2025
[8-K] Innoviva, Inc. Reports Material Event
Aug 5, 2025
[SCHEDULE 13G/A] Innoviva, Inc. SEC Filing
1.15B
62.11M
0.98%
110.79%
15.82%
Biotechnology
Pharmaceutical Preparations
United States
BURLINGAME